Precision Optics(POCI.US)

Company Encyclopedia
View More
name
Precision Optics
POCI.US
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States. The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. It also provides components and assemblies for industrial and military use.
1.378 T
POCI.USMarket value -Rank by Market Cap -/-

Financial Score

01/01/2026 Update
C
Health Care EquipmentIndustry
Industry Ranking98/175
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-57.98%E
    • Profit Margin-28.30%E
    • Gross Margin14.17%D
  • Growth ScoreB
    • Revenue YoY13.67%B
    • Net Profit YoY-60.76%D
    • Total Assets YoY29.85%A
    • Net Assets YoY7.75%B
  • Cash ScoreC
    • Cash Flow Margin-353.34%D
    • OCF YoY13.67%B
  • Operating ScoreA
    • Turnover1.09A
  • Debt ScoreC
    • Gearing Ratio51.20%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Precision Optics Reports Record Revenue Amid Growth Challenges

    Precision Optics Corporation reported record Q1 fiscal 2026 revenue of $6.7 million, a 46% increase from last year. The aerospace program saw an 800% revenue increase, while the cystoscope program grew by 180% year-over-year. Despite challenges with gross margins and a net loss of $1.6 million, the company remains optimistic about future profitability, projecting over $25 million in revenue for fiscal 2026. New development agreements in aerospace and defense sectors are expected to bolster growth.

    Tip Ranks·
    US
    POCI
    -0.59%
    Tip Ranks·
    US
    POCI
    -0.59%

    Precision Optics Reports Revenue Growth Amid Net Loss

    Precision Optics Corporation, Inc. reported a 59.2% increase in Q1 revenues to $6.68 million, driven by a nearly 300% rise in systems manufacturing revenue. Despite this, the company faced a net loss of $1.64 million due to higher operating expenses and lower gross margins. Management aims to improve operational efficiencies and capitalize on growth opportunities in the medical and defense sectors.

    Tip Ranks·
    US
    POCI
    -0.59%
    Tip Ranks·
    US
    POCI
    -0.59%

    Precision Optics Reports First Quarter Fiscal Year 2026 Financial Results

    Conference Call Scheduled for today, November 13, 2025, at 5:00pm ET Conference Call Scheduled for today, November 13, 2025, at 5:00pm ET ...

    GlobeNewswire·
    US
    POCI
    -0.59%
    GlobeNewswire·
    US
    POCI
    -0.59%

    Precision Optics Q1 revenue rises

    Precision Optics reported a 59% year-over-year increase in fiscal Q1 2026 revenue, reaching a record $6.7 million. Despite this growth, the company faced a net loss of $1.6 million and a decline in gross margins to 14.2%. The company projects FY 2026 revenue to exceed $25 million, with expected improvements in gross margins. Record production revenue was driven by demand from aerospace and surgical robotics sectors, while new agreements in AR systems and borescopes expand aerospace exposure.

    Reuters·
    US
    POCI
    -0.59%
    Reuters·
    US
    POCI
    -0.59%

    Precision Optics | 10-Q: FY2026 Q1 Revenue: USD 6.681 M

    LB filings·
    US
    POCI
    -0.59%
    LB filings·
    US
    POCI
    -0.59%
    © 2026 Longbridge｜Disclaimer